Nasalgen® IP

Pharmaceutical Name
Bovine Rhinotracheitis-Parainfluenza3 Vaccine, Modified Live Virus
Features and Benefits
... Convenience of one nostril administration to help protect calves when they need it most.
Helps protect healthy cattle against infectious bovine rhinotracheitis and parainfluenza3 virus.
Intranasal administration stimulates local and systemic antibodies.
Stimulates production of high levels of interferon.
Fast acting – early onset of protection (48 hours).
Safe – approved for use in pregnant cows and calves nursing pregnant cows.
Convenient – may be administered in one nostril or split between two.
Indications
For the vaccination of healthy cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis and parainfluenza3 virus.
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
Nasalgen® IP is a registered trademark of Schering-Plough Animal Health Corporation.
Species
